0      0

2021 AGA Postgraduate Course

25.96 - Use of blood testing for choosing, assessing and monitoring biologics in IBD

May 1, 2021 1:10pm ‐ May 1, 2021 2:00pm

Learning Objectives:
  • Identify laboratory testing needed prior to and after initiating a biologic to assess safety and efficacy
  • Identify when to use proactive and reactive therapeutic drug monitoring for biologics in IBD to improve efficacy and maintain efficacy
  • Interpret the meaning of biologic drug levels in the setting of proactive and reactive drug monitoring


  • Faten Aberra, MD, MSCE, Associate Professor of Medicine, University of Pennsylvania Medical Center

You must be logged in and own this session in order to post comments.